Protein

## Lalb_11388

Length
1,319 amino acids

### Protein family membership

None predicted.

### Homologous superfamilies

1. Homologous superfamily
   6 - 111
   - Zinc finger, RING/FYVE/PHD-type (IPR013083)

1 200 400 600 800 1000 1200 1319

### Domains and repeats

1. Domain
   21 - 60
   - Zinc finger, RING-type (IPR001841)
   156 - 220
   - RAWUL domain (IPR032443)

1 200 400 600 800 1000 1200 1319

### Detailed signature matches

1. IPR013083
   Zinc finger, RING/FYVE/PHD-type
   1. G3DSA:3.30.40.10 (Z...)
      6 - 111
      GENE3D
      G3DSA:3.30.40.10 (Zinc/RING finger domain)
2. IPR001841
   Zinc finger, RING-type
   1. SM00184 (ring_2)
      21 - 59
      SMART
      SM00184 (ring_2)
   2. PS50089 (ZF_RING_2)
      21 - 60
      PROSITE profiles
      PS50089 (ZF_RING_2)
3. IPR032443
   RAWUL domain
   1. PF16207 (RAWUL)
      156 - 220
      Pfam
      PF16207 (RAWUL)
4. IPR017907
   Zinc finger, RING-type, conserved site
   1. PS00518 (ZF_RING_1)
      37 - 46
      PROSITE patterns
      PS00518 (ZF_RING_1)

no IPR
Unintegrated signatures

1. G3DSA:3.10.20.90
   122 - 230
   GENE3D
   G3DSA:3.10.20.90 (G3DSA:3.10.20.90)
2. PF13923 (zf-C3HC4_2)
   21 - 59
   Pfam
   PF13923 (zf-C3HC4_2)
3. PTHR10825 (RING FIN...)
   9 - 416
   PANTHER
   PTHR10825 (RING FINGER DOMAIN-CONTAINING, POLYCOMB GROUP COMPONENT)
4. SSF57850 (RING/U-box)
   13 - 83
   SUPERFAMILY
   SSF57850 (RING/U-box)
5. cd16736 (RING-HC_PCGF4)
   15 - 68
   CDD
   cd16736 (RING-HC_PCGF4)
6. cd17082 (RAWUL_PCGF...)
   132 - 220
   CDD
   cd17082 (RAWUL_PCGF2_like)

### Other features

1. mobidb-lite (disord...)
   1,197 - 1,319
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   940 - 966
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   477 - 519
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   770 - 866
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   285 - 379
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   1,107 - 1,128
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   544 - 563
   MobiDB Lite
   mobidb-lite (disorder_prediction)
2. mobidb-lite (Polyam...)
   1,268 - 1,308
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   Feature: Polyampholyte
   1,230 - 1,252
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   Feature: Polyampholyte
   770 - 784
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   Feature: Polyampholyte
   335 - 374
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   Feature: Polyampholyte
3. mobidb-lite (Polar)
   481 - 519
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   Feature: Polar
   294 - 334
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   Feature: Polar
   943 - 966
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   Feature: Polar
   832 - 862
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   Feature: Polar
   1,197 - 1,229
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   Feature: Polar
   789 - 824
   MobiDB Lite
   mobidb-lite (disorder_prediction)
   Feature: Polar

### Residue annotation

1. polypeptide substr...
   18Q
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   20T
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   24C
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   26G
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   27Y
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   29I
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   30D
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   32T
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   33T
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   35I
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   36E
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   37C
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   38L
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   39H
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   42C
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   43R
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   44S
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   45C
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   47V
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
   48K
   polypeptide substrate binding site
   18Q, 20T, 24C, 26G, 27Y, 29I, 30D, 32T, 33T, 35I, 36E, 37C, 38L, 39H, 42C, 43R, 44S, 45C, 47V, 48K
   CDD
   cd16736 (RING-HC_PCGF4)
2. Zn binding site cd...
   21C
   Zn binding site
   21C, 24C, 37C, 39H, 42C, 45C, 56C, 59C
   CDD
   cd16736 (RING-HC_PCGF4)
   24C
   Zn binding site
   21C, 24C, 37C, 39H, 42C, 45C, 56C, 59C
   CDD
   cd16736 (RING-HC_PCGF4)
   37C
   Zn binding site
   21C, 24C, 37C, 39H, 42C, 45C, 56C, 59C
   CDD
   cd16736 (RING-HC_PCGF4)
   39H
   Zn binding site
   21C, 24C, 37C, 39H, 42C, 45C, 56C, 59C
   CDD
   cd16736 (RING-HC_PCGF4)
   42C
   Zn binding site
   21C, 24C, 37C, 39H, 42C, 45C, 56C, 59C
   CDD
   cd16736 (RING-HC_PCGF4)
   45C
   Zn binding site
   21C, 24C, 37C, 39H, 42C, 45C, 56C, 59C
   CDD
   cd16736 (RING-HC_PCGF4)
   56C
   Zn binding site
   21C, 24C, 37C, 39H, 42C, 45C, 56C, 59C
   CDD
   cd16736 (RING-HC_PCGF4)
   59C
   Zn binding site
   21C, 24C, 37C, 39H, 42C, 45C, 56C, 59C
   CDD
   cd16736 (RING-HC_PCGF4)

### GO term prediction

#### Biological Process

None predicted.

#### Molecular Function

None predicted.

#### Cellular Component

None predicted.

Generated with InterProScan 5.45-80.0